Dacogen User Fee Date Is May 15
This article was originally published in The Pink Sheet Daily
Executive Summary
MGI/SuperGen's myelodysplastic syndromes injection therapy Dacogen (decitabine) has a new user fee date of May 15, 2006
You may also be interested in...
SuperGen Orathecin Hits Road Block: Phase III Nixed For Combo Claim In Pancreatic Cancer
Phase II trial fails to meet pre-specified threshold for median survival.
SuperGen Orathecin Hits Road Block: Phase III Nixed For Combo Claim In Pancreatic Cancer
Phase II trial fails to meet pre-specified threshold for median survival.
MGI/SuperGen’s Dacogen Is “Approvable” Pending Transfusion Data Analysis
Companies expect to submit requested data to FDA early in the fourth quarter for the myelodysplastic syndromes therapy.